In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials
Sign Up to like & getrecommendations! Published in 2024 at "Advanced Materials"
DOI: 10.1002/adma.202310168
Abstract: In the past decade, adoptive cell therapy with chimeric antigen receptor‐T (CAR‐T) cells has revolutionized cancer treatment. However, the complexity and high costs involved in manufacturing current adoptive cell therapy greatly inhibit its widespread availability… read more here.
Keywords: cell therapy; immune cells; reprogramming immune; synthetic nanomaterials ... See more keywords